세포 트랜스펙션 시장 규모, 점유율, 성장 분석 : 트랜스펙션 방법별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Cell Transfection Market size was valued at USD 2.4 Billion in 2024 and is poised to grow from USD 2.62 Billion in 2025 to USD 5.34 Billion by 2033, growing at a CAGR of 9.3% during the forecast period (2026-2033).

The global cell transfection market is driven by an increasing demand for innovative gene-modification tools in various sectors, including academia, industry, and clinical applications. Efficient nucleic acid delivery is crucial for advancements in areas such as functional genomics and the development of cell and gene therapies. There has been a notable transition from non-viral chemical reagents to optimized electroporation systems and viral vectors, as efficiency and scalability become paramount. Additionally, a growing prevalence of cell and gene therapies, like CAR-T, heightens the need for robust transfection methods, prompting suppliers to enhance their offerings. AI is transforming this landscape by optimizing design and workflows, creating integrated solutions that enhance reproducibility, decrease development time, and stimulate partnerships in biopharma and biotechnology ecosystems.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Transfection market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Transfection Market Segments Analysis

Global cell transfection market is segmented by transfection methods, end users and region. Based on transfection methods, the market is segmented into Electroporation, Lipofection, Calcium Phosphate, Viral Transfection and Others. Based on end users, the market is segmented into Academic Institutes, Pharmaceutical Companies, Biotechnology Companies and Contract Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cell Transfection Market

The growth in research dedicated to gene therapies and nucleic acid-based medicines has significantly fueled the demand for effective cell transfection solutions. Researchers require dependable methods to deliver genetic material into various cell types for their discovery and preclinical development efforts. This scientific emphasis drives laboratories and contract research organizations to invest in validated transfection reagents and platforms that facilitate complex workflows. In response, suppliers are expanding their product offerings and enhancing performance characteristics. As a result, ongoing research endeavors stimulate innovation and commercialization within the transfection sector, strengthening supply chains and improving competitive options in the market.

Restraints in the Global Cell Transfection Market

The Global Cell Transfection market faces significant constraints due to high and variable costs associated with premium transfection reagents, specialized delivery systems, and automation platforms. These financial barriers particularly impact academic laboratories and smaller service providers, hindering their ability to procure necessary materials and limiting market penetration. Budget constraints often force researchers to favor established techniques over newer, pricier innovations, which can stifle demand for cutting-edge products. Additionally, cost sensitivity restricts necessary investment in the validation and optimization of methods needed for routine application, ultimately diminishing commercial adoption and discouraging suppliers from expanding their product ranges or exploring niche opportunities.

Market Trends of the Global Cell Transfection Market

The global cell transfection market is experiencing a significant upward trajectory driven by the increasing demand for precise and low-toxicity delivery methods in single cell applications. Researchers are focusing on advanced transfection techniques that maintain cell viability while facilitating robust expression essential for downstream omics workflows. This trend is prompting the development of scalable and gentle technologies compatible with microfluidic platforms, enhancing integration with single cell sequencing and high content analysis. As vendors prioritize reproducibility and ease of integration, cell transfection is emerging as a critical enabler for discovery, biomarker identification, therapeutic development, and clinical applications across various sectors.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Cell Transfection Market Size by Transfection Methods & CAGR (2026-2033)

• Market Overview
• Electroporation
• Lipofection
• Calcium Phosphate
• Viral Transfection
• Others

Global Cell Transfection Market Size by End Users & CAGR (2026-2033)

• Market Overview
• Academic Institutes
• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organizations

Global Cell Transfection Market Size & CAGR (2026-2033)

• North America (Transfection Methods, End Users)
  • US
  • Canada
• Europe (Transfection Methods, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Transfection Methods, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Transfection Methods, End Users)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Transfection Methods, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OriGene Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MaxCyte, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• POLYPLUS TRANSFECTION
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ATCC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellink
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EMD Millipore
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SignaGen Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mirus Bio LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellecta, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations